申请人:Synthelabo
公开号:US05010079A1
公开(公告)日:1991-04-23
An indolone derivative is useful for the treatment of anxiety, depression and schizophrenia and is a 5HT.sub.1A agonist and 5HT.sub.2 antagonist, which is a compound of formula (I): ##STR1## in which R.sub.1 is a hydrogen or halogen atom or a (C.sub.1-4)alkyl radical, R.sub.2 is a hydrogen atom or a (C.sub.1-4)alkyl radical, R.sub.3 is a hydrogen atom, a (C.sub.1-4)alkyl radical or an S-(C.sub.1-4) alkyl radical; and R.sub.4 is a phenyl, chlorophenyl, naphthyl, 7-methoxy-1-naphthyl, 6-methoxy-1-indanyl, 2-methoxy-6-pyridyl, 3-methoxy-2-pyridyl, isoquinolyl, 7-methoxy-1-isoquinolyl, 7-methoxy-1,2,3,4-tetrahydro-1-naphthyl or 7-fluoro-1-naphthyl radical; or a pharmaceutically acceptable acid addition salt thereof.
一种吲哚酮衍生物对焦虑、抑郁和精神分裂症的治疗具有用处,是一种5HT.sub.1A激动剂和5HT.sub.2拮抗剂,其化学式为(I):##STR1## 其中R.sub.1是氢原子或卤素原子或(C.sub.1-4)烷基基团,R.sub.2是氢原子或(C.sub.1-4)烷基基团,R.sub.3是氢原子、(C.sub.1-4)烷基基团或S-(C.sub.1-4)烷基基团;R.sub.4是苯基、氯苯基、萘基、7-甲氧基-1-萘基、6-甲氧基-1-茚基、2-甲氧基-6-吡啶基、3-甲氧基-2-吡啶基、异喹啉基、7-甲氧基-1-异喹啉基、7-甲氧基-1,2,3,4-四氢-1-萘基或7-氟-1-萘基基团;或其药学上可接受的酸盐。